bit.bio

bit.bio is a synthetic biology and cell programming company based in Cambridge, United Kingdom.

Founded in 2016 by Dr. Mark Kotter, the company focuses on manufacturing human cells with high consistency and purity at an industrial scale. bit.bio aims to address the challenges in cell therapies and research by providing a reliable source of human cells, leveraging its proprietary opti-oxTM technology for precise cell programming. The company offers a range of services, including custom cell programming, large-scale cell manufacturing, and disease modeling support. Its product line, branded as ioCellsTM, features various pre-programmed human cells, such as neurons, immune cells, and muscle cells, designed for research and drug discovery. bit.bio serves a diverse clientele, including pharmaceutical companies, academic institutions, and firms involved in toxicology and regenerative medicine, positioning itself as a leader in the field of cell manufacturing.